Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS FEBRUARY ISSUE PUBLISHED
  • FEBRUARY 2021 Issue has been successfully launched on 1 February 2021.

Abstract

SOME PHARMACOLOGICAL STUDIES ON ANTIBACTERIAL DRUG PROTECTIVE EFFECTS OF GINSENG ON CEFTRIAXONE-INDUCED HEPATIC INJURY IN RATS

Ashraf Abd El Hakeem Elkomy, Samar Saber Ibrahim Mohamed and *Mahmmoud Elsayed Mahmmoud Elmehalawy

 

ABSTRACT

Ceftriaxone is a broad-spectrum semisynthetic cephalosporin antibiotic that causes partial damage in the liver manifested by transient elevation in some biochemical parameters. In this study, our aim was to investigate the use of Ginseng in prevention of the hepatotoxic effect and biochemical changes induced by ceftriaxone in rats. Rats were divided into Five groups (control, ceftriaxone 180 mg/kg, Ginseng + ceftriaxone 180 mg/kg, cef- triaxone 360 mg/kg, and Ginseng + ceftriaxone 360 mg/kg). Ceftriaxone was injected intraperitone- ally, and Ginseng was given orally daily for four consecutive weeks. Then liver functions (serums AST, ALT, ALP, direct bilirubin, and total protein) were assessed. Histopathological examination was performed. Treatment of animals with ceftriaxone caused elevated activities of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as well as total bilirubin level. These elevations in liver enzymes were decreased by combination ceftriaxone with Ginseng. In addition, cef- triaxone caused a significant increase in malondialdehyde (MDA) and nitric oxide (NO) content but significant decrease in glutathione (GSH) content. Combination of GINSENG and ceftriaxone resulted in a significant decrease in MDA, NO content and significantly elevated GSH content. It could be concluded that GINSENG acts as an effective hepatoprotective agent against liver dysfunction caused by ceftriaxone, and this effect might be related to its antioxidant properties. Hepatic functions should be monitored, and the dose should be adjusted during ceftriaxone therapy.

Keywords: Ceftriaxone; GINSENG Hepatotoxicity; Liver, Kidney Protective Role.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More